Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCD for Refractory or Relapsed Peripheral T-cell Lymphoma
NCT02424045Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- May 2015
- Primary completion
- Sep 2017
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
01
Overview
A Phase 2 trial of bendamustine, carboplatin, dexamethasone in peripheral T-cell lymphoma (PTCL), sponsored by Samsung Medical Center. Started May 2015; status: completed.
02
Drugs
bendamustinecarboplatindexamethasone
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02424045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424045.